A University of Alabama at Birmingham Heersink School of Medicine-led study suggests that first-time transient ischemic ...
For patients with acute ischemic stroke (AIS) whose symptoms began 4.5 to 24 hours earlier, alteplase is associated with a higher percentage of patients achieving a score of 0 or 1 on the modified ...
In any case, there was no mortality signal associated with alteplase administered up to 24 hours after a stroke in HOPE.
The challenges of translating neuroprotective interventions with promising efficacy in animal studies into effective treatments for patients with stroke are well documented, with issues including ...
The GLP-1 liraglutide showed potential benefit in reducing stroke recurrence and improving functional outcomes after minor ...
The following is a summary of “Hyponatremia is associated with malignant brain edema after mechanical thrombectomy in acute ...
In a randomized clinical trial, giving the clot-busting medication alteplase up to 24 hours after stroke symptoms first appeared increased the odds of better recovery by 50% compared to those who ...
Three trials showed no improvement in functional outcomes, and the potential for harm, versus medical therapy alone.
Researchers continue to advance the science to determine best treatments for stroke. Based on an international study of 530 patients, researchers discovered that while the clot retrieval procedure ...
(Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the world's first ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results